BACKGROUND: Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are a significant cause of morbidity and mortality for patients with COPD. AECOPD are the leading cause of hospital admissions in Canada. Although multiple guidelines have been developed for the acute and chronic management of COPD, there are few quality assurance studies investigating adherence to these guidelines. METHODS: A retrospective chart review of all patients admitted to a tertiary care hospital in 2009 for an AECOPD was performed. Using a standardized data abstraction tool, adherence to current guidelines across different physician groups and patient outcomes were assessed. Particular focus was centred on differences in management across physician groups. RESULTS: Overall, 293 patients were evaluated. Of these, 82.6% were treated with one or more chronic COPD medication(s) in the community, with only 17.7% of patients treated with a long-acting inhaled anticholinergic medication. For treatment of AECOPD, 58% of patients received corticosteroids and 84% received antibiotics. Compared with general medicine and the hospitalist service, the respiratory medicine service demonstrated significantly better adherence with current treatment guidelines; however, even this was less than optimal. In addition, there was poor follow-up of patients cared for outside of the respiratory service. CONCLUSIONS: The present study identified significant care gaps in the treatment of patients admitted with AECOPD and on their discharge.
BACKGROUND: Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are a significant cause of morbidity and mortality for patients with COPD. AECOPD are the leading cause of hospital admissions in Canada. Although multiple guidelines have been developed for the acute and chronic management of COPD, there are few quality assurance studies investigating adherence to these guidelines. METHODS: A retrospective chart review of all patients admitted to a tertiary care hospital in 2009 for an AECOPD was performed. Using a standardized data abstraction tool, adherence to current guidelines across different physician groups and patient outcomes were assessed. Particular focus was centred on differences in management across physician groups. RESULTS: Overall, 293 patients were evaluated. Of these, 82.6% were treated with one or more chronic COPD medication(s) in the community, with only 17.7% of patients treated with a long-acting inhaled anticholinergic medication. For treatment of AECOPD, 58% of patients received corticosteroids and 84% received antibiotics. Compared with general medicine and the hospitalist service, the respiratory medicine service demonstrated significantly better adherence with current treatment guidelines; however, even this was less than optimal. In addition, there was poor follow-up of patients cared for outside of the respiratory service. CONCLUSIONS: The present study identified significant care gaps in the treatment of patients admitted with AECOPD and on their discharge.
Authors: Peter K Lindenauer; Penelope Pekow; Shan Gao; Allison S Crawford; Benjamin Gutierrez; Evan M Benjamin Journal: Ann Intern Med Date: 2006-06-20 Impact factor: 25.391
Authors: Shawn D Aaron; Katherine L Vandemheen; Dean Fergusson; François Maltais; Jean Bourbeau; Roger Goldstein; Meyer Balter; Denis O'Donnell; Andrew McIvor; Sat Sharma; Graham Bishop; John Anthony; Robert Cowie; Stephen Field; Andrew Hirsch; Paul Hernandez; Robert Rivington; Jeremy Road; Victor Hoffstein; Richard Hodder; Darcy Marciniuk; David McCormack; George Fox; Gerard Cox; Henry B Prins; Gordon Ford; Dominique Bleskie; Steve Doucette; Irvin Mayers; Kenneth Chapman; Noe Zamel; Mark FitzGerald Journal: Ann Intern Med Date: 2007-02-19 Impact factor: 25.391
Authors: John R Hurst; Gavin C Donaldson; Jennifer K Quint; James J P Goldring; Ramin Baghai-Ravary; Jadwiga A Wedzicha Journal: Am J Respir Crit Care Med Date: 2008-12-12 Impact factor: 21.405
Authors: Denis E O'Donnell; Paul Hernandez; Alan Kaplan; Shawn Aaron; Jean Bourbeau; Darcy Marciniuk; Meyer Balter; Gordon Ford; Andre Gervais; Yves Lacasse; Francois Maltais; Jeremy Road; Graeme Rocker; Don Sin; Tasmin Sinuff; Nha Voduc Journal: Can Respir J Date: 2008 Jan-Feb Impact factor: 2.409
Authors: Laura J Spece; Lucas M Donovan; Matthew F Griffith; Margaret P Collins; Laura C Feemster; David H Au Journal: COPD Date: 2018-10 Impact factor: 2.409
Authors: Beatrice Huang; Rachel Willard-Grace; Denise De Vore; Jessica Wolf; Chris Chirinos; Stephanie Tsao; Danielle Hessler; George Su; David H Thom Journal: BMC Pulm Med Date: 2017-06-09 Impact factor: 3.317
Authors: Abdulmajeed Alshabanat; Michael C Otterstatter; Don D Sin; Jeremy Road; Carmen Rempel; Jane Burns; Stephan F van Eeden; J M FitzGerald Journal: Int J Chron Obstruct Pulmon Dis Date: 2017-03-21
Authors: Sachin R Pendharkar; Maria B Ospina; Danielle A Southern; Naushad Hirani; Jim Graham; Peter Faris; Mohit Bhutani; Richard Leigh; Christopher H Mody; Michael K Stickland Journal: BMC Pulm Med Date: 2018-05-30 Impact factor: 3.317
Authors: Swati Gulati; Aline N Zouk; Jonathan P Kalehoff; Christopher S Wren; Peter N Davison; Denay Porter Kirkpatrick; Surya P Bhatt; Mark T Dransfield; James Michael Wells Journal: Int J Chron Obstruct Pulmon Dis Date: 2018-07-27